Market Focus

Gilead Sciences

Gilead Sciences posted blow out earnings after the market close today. Revenue came in more than $1 billion over estimates. Results were boosted by the company’s new treatment for hepatitis C. Shares were halted after the announcement. When the stock reopened, shares initially rose after hours. The stock was up about two percent in the regular session closing at $72.86.


Also after the close, Amgen posted earnings that missed estimates. Its results were hurt by acquisition-related costs and products and its earnings fell short of expectations. The company did reiterate its full-year forecast for earnings. Shares initially fell after hours. The stock closed the regular session up about two percent to $119.30.

Harley Davidson

Harley Davidson’s earnings topped estimates. The motorcycle maker saw first-quarter profit jump nearly 20 percent, helped by strong overseas sales. Sales in the U.S. were also up despite the harsh winter weather, which reduced traffic at its dealerships. Shares surged almost 6.5 percent to $71.87.


JetBlue Airways’ pilots voted to join the Air Line Pilot Association union. About 70 percent of the company’s pilots voted in favor of the move. Shares fell two percent to $8.59.

Intuitive Surgical

Shares of Intuitive Surgical got a lift on news the Food and Drug Administration cleared its da Vinci Sp Surgical System. The medical device is designed to assist in urological surgical procedures and it will be used with Intuitive’s other robotic surgical machine. The stock popped almost three percent to $422.33.

This entry was posted in Market Focus. Bookmark the permalink.

Leave a Reply